Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a Canada-based pharmaceutical company. The Company is focused on the development and commercialization of therapies for the United States cardiovascular market. The focus of the Company is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company’s United States subsidiary, Medicure Pharma Inc. The Company also operates Marley Drug, Inc. (Marley Drug), a pharmacy located in North Carolina that offers an Extended Supply drug program serving all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving the health status of its patients and the communities they serve while reducing overall health care costs for employers and other health care consumers. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).

TSXV:MPH - Post by User

Medicure Inc

Bullboard Posts

Comment by eSnowdenon Feb 16, 2020 7:25pm

167 Views

Post# 30698128

RE:RE:RE:Another Share Buyback

I haven't called them, but I have emailed investor relations numerous times & never received a response. I am critical of the company...this was once a $200m company now valued at $30m. The analyst that followed the co. has given up...the windfall from the apicore sale has been squandered, except for the tender offer. Friesen needs to offer investors something positive to get the share price out of this rut.

Bullboard Posts

2024, a breakthrough year for silver